Skip to main content
. 2020 Oct 6;12(10):2870. doi: 10.3390/cancers12102870
AKT Protein kinase B
APC Antigen presenting cell
APE1 Apurinic/apyrimidinic endonuclease 1
BAD BCL2 associated agonist of cell death
BRAF v-Raf murine sarcoma viral oncogene homolog B
CAFs Cancer-associated fibroblasts
CAR-T Chimeric antigen receptor T-cells
CCL2 C-C Motif Chemokine Ligand 2
CCL-22 C-C motif chemokine 22
CD Cluster differentiation
CRAF v-raf1 murine leukemia viral oncogene homolog 1
CTL Cytotoxic lymphocytes
CTLA-4 cytotoxic T-lymphocyte-associated protein 4
CXCL-2 CXC chemokine ligand 2
CXCL5 CXC motif chemokine 5
DCs Dendritic cells
DNAM-1 DNAX accessory molecule-1
ECM Extracellular matrix
EMT Epithelial mesenchymal transition
ErbB3 V-erb-b2 avian erythroblastic leukemia viral oncogene homolog3
ERK Extracellular signal-regulated kinase
FAK Focal adhesion kinase
FAP Fibroblast activation protein
FcγR Fragment crystallizable-gamma receptor
FDA Food and Drug Administration
FGF 2-19 Fibroblast growth factor 2-19
FGFR-3 Fibroblast growth factor receptor 3
FSP1 Fibroblast specific protein 1
GSK3β Glycogen synthase kinase 3 beta
Gp Glycoprotein
HER3 V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3
HGF Hepatocyte growth factor
ICIs Immune checkpoint inhibitors
IDO Indoleamine-2,3-dioxygenase
Ig Immunoglobulin
IGF-1 Insulin-like growth factor 1
IGF-1R Insulin-like growth factor receptor 1
IL Interleukin
ITIM Immunoreceptor tyrosine-based inhibition motif
KIT v-kit Hardy–Zuckerman 4 feline sarcoma viral oncogene homolog
LIPA Lysosomal acid lipase A
MAPK Mitogen-activated protein kinase
MCL-1 Myeloid leukemia cell protein 1
MCH-I Major histocompatibility complex 1
MDSCs Myeloid-derived suppressor cells
MEK Mitogen-activated protein kinase kinase
MET Mesenchymal epithelial transition receptor
MHC Major histocompatibility complex
miRNA microRNA
MITF Microphthalmia-associated transcription factor
MMPs Matrix metalloproteinases
NFkB Nuclear factor kappa-light-chain-enhancer of activated B cells
NGS Next-generation sequencing
NK Natural killer
NKG2D Natural killer group 2D
NRAS Neuroblastoma RAS viral oncogene homolog
NRG-1 Neuregulin 1
ORR Objective response rate
OS Overall survival
PBMC Peripheral blood mononuclear cells
PD-1 Programmed cell death protein 1
PDGFR Platelet-derived growth factor receptor
PDL-1/2 Programmed death ligands 1/2
PI3K Phosphatidyl Inositol 3-kinase
PFS Progression-free survival
PTEN Phosphatase and tensin homolog on chromosome 10
ROS Reactive oxygen species
RTK Tyrosine kinase receptor
sFRP2 Secreted frizzled-related protein 2
STAT Signal transducer and activator of transcription
SRC V-src sarcoma (Schmidt–Ruppin A-2) viral oncogene homolog avian
TAB Tumor-associated B cells
TAMs Tumor-associated macrophages
TCF7 Transcription factor 7
TGF-β Transforming growth factor β
TIGIT T cell Ig and ITIM domain
TIL Tumor-infiltrating lymphocytes
Tim3 Immunoglobulin and mucin domain-containing molecule 3
TME Tumor microenvironment
TNFα Tumor necrosis factor α
TRAF6 Tumor necrosis factor receptor-associated factor 6
Tregs Regulatory T cells
VEGF Vascular endothelial growth factor
VISTA V-domain Ig suppressor of T cell activation
Wnt wingless type MMTV integration site family member
α-SMA α smooth muscle actin